[ad_1]
Recent news has the weight loss industry wound up. This maybe wound up positively or negatively depending on what side you are on. The issue at hand is some new obesity medications that have been submitted to the FDA for the fight on obesity. They have gone though years of testing and if all goes well they may be available via prescription within a year.
You don't have to read very much or go very far before you see something about the state of the USA reaching higher and higher levels of obesity. The reasons also abundant and they most often are a result of multiple infractions on ones health. The majority of the obesity in our nation is a result of poor diet and or a lack of exercise. Many culprits are to blame such as the many conveniences of society but ultimately it comes down to decisions made by each individual. On the flip side, there are also circumstances in which obesity may not be totally the fault of an individual. There can be other diseases that will actually prohibit one from losing weight by affecting levels of certain hormones in ones system. Then there is also the genetic issue, some people and their families are just generally overweight.
Prescription Diet Pills have been around for years but there are some new medications on the horizon that may end up being passed by the FDA and give obese people some other options to current medications on the market. The most recent ones that are being studied are Qnexa, Lorcaserin and Contrave, with the first 2 already having been submitted to the FDA at the time of this writing and Contrave expected to be submitted sometime early 2010. Whatever ones situation may be, it is very important that each person speak to their doctor about weight loss and obesity issues. Each person's case is different and thus each treatment can vary from one person to the next. Prescription obesity medication may or may not be prescribed by a doctor for each individual. It is not up to anyone other than a trained medical professional to determine this.
[ad_2]
Source by Scotty Smith
No comments:
Post a Comment